At the news
? NEUTRALIMPACT 3/10 144 filed Apr 13, 2026 at 16:18 ET
David Rodman, an officer of Mineralys Therapeutics, filed a Form 144 to notify intent to sell up to 14,058 shares of common stock, following a series of prior cashless exercises of stock options. This proposed sale is part of an ongoing pattern of insider transactions over the past several months.
- David Rodman, an officer, filed Form 144 to sell up to 14,058 shares.
- The shares are from a broker-assisted cashless exercise of employee stock options on April 13, 2026.
- Rodman has conducted multiple similar transactions between January and April 2026, totaling over 77,000 shares sold.
- No unusual timing relative to earnings or major catalysts is indicated.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access